Profile data is unavailable for this security.
About the company
Oncoarendi Therapeutics SA is a Poland-based biopharmaceutical company . The Company is dedicated to discovering, developing and commercializing therapeutics for neoplastic and inflammatory diseases. The Company's business model is focused on drug discovery and development, with its core strength in medicinal chemistry and preclinical biology, enhanced by scientific collaborations in specific disease areas. The Company has a platform of 3 distinct small molecule programs targeting chitinases hydrolytic enzymes with potential utility in diverse inflammatory and fibrotic diseases of high unmet medical need. Additionally, it has initiated a program focused on development of small molecule immune modulators to stop the ability of tumors to escape immune surveillance.
- Revenue in PLN (TTM)355.10k
- Net income in PLN-25.51m
- Incorporated2017
- Employees113.00
- LocationMolecure SAZwirki I Wigury 101WARSZAWA 02-089PolandPOL
- Phone+48 225526724
- Websitehttps://molecure.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GENOMED SA | 22.14m | 588.66k | 36.73m | 44.00 | 62.40 | 3.96 | 30.76 | 1.66 | 0.4455 | 0.4455 | 16.75 | 7.02 | 2.17 | 5.85 | 14.12 | 503,111.40 | 5.77 | 7.77 | 6.39 | 9.19 | 44.00 | 38.53 | 2.66 | 3.87 | 4.64 | 30,446.00 | 0.00 | -- | 9.88 | 3.88 | 174.07 | -8.94 | -32.19 | -- |
Read Gene SA | 11.63m | -1.00m | 66.97m | 11.00 | -- | 35.89 | -- | 5.76 | -0.1084 | -0.1084 | 1.16 | 0.1583 | 0.9731 | 51.32 | 18.69 | -- | -8.40 | -1.06 | -8.56 | -1.31 | 92.67 | 88.41 | -8.63 | -2.42 | 23.52 | -2.46 | 0.00 | -- | 40.14 | 16.00 | -731.53 | -- | -- | -- |
Pure Biologics SA | 68.00k | -23.01m | 68.31m | 11.00 | -- | -- | -- | 1,004.63 | -7.09 | -8.27 | 0.0211 | -1.82 | 0.0016 | -- | 0.469 | 1,333.33 | -53.52 | -65.91 | -85.74 | -109.50 | -1,457.35 | 6.97 | -33,838.23 | -487.38 | -- | -7.36 | -- | -- | -85.65 | -60.22 | -39.41 | -- | 1.65 | -- |
Sds Optic SA | 370.00 | -8.98m | 78.17m | -- | -- | -- | -- | 211,274.10 | -1.52 | -1.52 | 0.00006 | -0.0545 | 0.00003 | 65.75 | 0.0006 | -- | -74.69 | -- | -86.32 | -- | -371,002.80 | -- | -2,452,795.00 | -- | 9.61 | -47.49 | -- | -- | -99.61 | -- | -85.09 | -- | -- | -- |
Genomtec SA | 2.00k | -11.00m | 90.34m | -- | -- | 7.69 | -- | 45,170.31 | -0.8971 | -0.8971 | 0.0002 | 0.9582 | 0.00009 | 62.24 | 0.0011 | -- | -47.25 | -- | -60.10 | -- | -115,050.00 | -- | -549,850.00 | -- | 2.06 | -88.39 | 0.1442 | -- | -97.50 | -- | 24.44 | -- | -- | -- |
Nanogroup SA | 1.02k | -7.12m | 98.50m | -- | -- | 12.24 | -- | 96,570.91 | -0.3541 | -0.3541 | 0.00005 | 0.3253 | 0.00007 | 7.84 | 0.0141 | -- | -45.22 | -23.18 | -51.42 | -26.06 | -99,397.06 | -278.03 | -692,468.60 | -1,567.57 | 2.75 | -858.81 | 0.00 | -- | -98.55 | -55.07 | -840.84 | -- | -8.99 | -- |
Urteste SA | 0.00 | -4.28m | 132.51m | -- | -- | 5.12 | -- | -- | -3.15 | -3.15 | 0.00 | 18.34 | 0.00 | 11.94 | -- | -- | -14.28 | -- | -14.78 | -- | -- | -- | -- | -- | 17.80 | -- | 0.026 | -- | -100.00 | -- | -37.59 | -- | -- | -- |
Molecure SA | 355.10k | -25.51m | 179.47m | 113.00 | -- | 2.08 | -- | 505.41 | -1.52 | -1.52 | 0.0211 | 5.13 | 0.0032 | -- | 0.4907 | 3,199.10 | -22.88 | 2.64 | -23.91 | 2.76 | -542.79 | 97.54 | -7,184.10 | 12.84 | -- | -- | 0.0657 | -- | -18.85 | 237.24 | -19.67 | -- | -24.82 | -- |
Poltreg SA | 600.00k | -17.42m | 250.89m | 23.00 | -- | 3.16 | -- | 418.16 | -3.74 | -3.74 | 0.1287 | 17.04 | 0.0051 | 27.12 | 3.22 | 26,373.63 | -14.82 | -6.51 | -16.41 | -7.35 | -1,804.83 | -391.38 | -2,903.50 | -449.24 | 4.21 | -- | 0.0913 | -- | 40.04 | -- | -588.92 | -- | 214.26 | -- |
Mabion SA | 139.86m | 37.39m | 260.86m | 226.00 | 6.98 | 1.79 | 5.66 | 1.87 | 2.31 | 2.31 | 8.65 | 9.01 | 0.7538 | 4.02 | 17.35 | 618,836.30 | 20.15 | -7.19 | 25.09 | -16.79 | 78.30 | 58.10 | 26.73 | -14.27 | 1.64 | 101.63 | 0.026 | -- | -7.50 | -- | 77.94 | -- | 40.86 | -- |
BIOTON SA | 186.32m | -6.85m | 286.79m | 358.00 | -- | 0.4791 | 11.13 | 1.54 | -0.0797 | -0.0797 | 2.17 | 6.97 | 0.2303 | 1.02 | 21.19 | 520,435.80 | -0.8464 | -1.99 | -1.04 | -2.47 | 33.80 | 45.33 | -3.67 | -8.61 | 0.2085 | 0.3295 | 0.0864 | -- | -22.10 | -5.51 | 60.10 | -38.69 | 0.3284 | -- |
Captor Therapeutics SA | 18.64m | -46.69m | 331.06m | 104.00 | -- | 6.53 | -- | 17.76 | -10.29 | -10.29 | 4.08 | 10.87 | 0.2391 | -- | 5.26 | 179,230.80 | -59.88 | -- | -83.65 | -- | 51.97 | -- | -250.46 | -- | -- | -- | 0.1114 | -- | 44.15 | -- | -96.65 | -- | -- | -- |
Scope Fluidics SA | 98.00k | -26.68m | 444.33m | 40.00 | -- | 6.58 | -- | 4,533.95 | -9.79 | -9.79 | 0.036 | 24.76 | 0.001 | 2.53 | 0.0716 | 2,450.00 | -27.04 | 52.74 | -28.55 | 57.32 | -2,013.27 | -420.87 | -27,227.55 | 30,134.78 | 11.32 | -- | 0.0301 | -- | 27.72 | -- | -105.76 | -- | 89.99 | -- |
Holder | Shares | % Held |
---|---|---|
Nationale-Nederlanden PTE SAas of 30 Jun 2023 | 845.00k | 5.02% |
Allianz Polska PTE SAas of 29 Dec 2023 | 714.15k | 4.24% |
Norges Bank Investment Managementas of 31 Dec 2023 | 498.67k | 2.96% |
Allianz Polska TFI SAas of 31 Dec 2023 | 327.84k | 1.95% |
Goldman Sachs Towarzystwo Funduszy Inwestycyjnych SAas of 31 Dec 2022 | 55.16k | 0.33% |